DOCSLIB.ORG

Protecting Children in Substance-Abusing Families

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Protecting Children in Substance-Abusing Families If you have issues viewing or accessing this file contact us at NCJRS.gov. National Ce~'ter on Child Abuse and Neglect Protecting Children in Substance-Abusing Families The lJser Manual Series U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Administration on Children, Youth and Families National Center on Child Abuse and Neglect Protecting Children in Substance-Abusing Families Vickie Kropenske and Judy Howard with Cheryl Breitenbach Richard Dembo Susan B. Edelstein Kathy McTaggart Annette Moore Mary Beth Sorensen Virginia Weisz 1994 U.S. Department of Health and Human Services Administration for Children and Families Administration on Children, Youth and Families National Center on Child Abuse and Neglect This manual, and other manuals in the series, are available from: The Clearinghouse on Child Abuse and Neglect Information P.O. Box 1182 Washington, D.C. 20013 146951 U.S. Department of Justice National Institute of Justice This document has been reproduced exactly as received from the person or organization originating it. Points of view or opinions stated in this document are those of the authors and do not necessarily represent the official position or policies of the National Institute of Justice. Permission to reproduce this material has been granted by I..' Public Domain/U.S. Dept. of Health and Human Services to the National Criminal Justice Reference Service (NCJRS). Further reproduction outside of the NCJRS system requires permission of the ~ owner. This manual was developed and produced by Circle Solutions, Inc., McLean, VA., under subcontract No. HHS 105-89-1730 with Westover Consultants, Inc. l_ - -------------~~~~~~~~~~~~~~~~~~-'---~~~~~~~~-.----------------' TABLE OF CONTENTS PREFACE ix ACKNOWLEDGMENTS xi INTRODUCTION xiii IDENTIFYING ALCOHOL AND/OR OTHER DRUG USE 1 Physical and Behavioral Indications of Substance Abuse in Families 1 Physical and Behavioral Indications of Perinatal Substance Abuse 2 Physical and Behavioral Indications of Relapse for Individuals in Recovery 2 Diagnostic Tests for Alcohol Use 2 Toxicology Screening for Drug Use 3 Surrunary 4 CHEMICALLY INVOLVED PARENTS: CHARACTERISTICS OF PARENTS AT RISK 5 The Nature of Substance Abuse 6 The Chemically Involved Parent 8 Childhood Deprivation 8 Survival Needs 8 Psychiatric Disorders 9 Denial 9 The Needs of Children and Parenting Tasks· 10 Summary 11 CIDLDREN OF CHEMICALLY INVOLVED PARENTS: SPECIAL RISKS 13 Neonatal and Infant Complications 14 Neurological Symptoms 14 Prematurity 16 Intracranial Hemorrhages 16 Bronchopulmonary Dysplasia (BPD) 16 Retinopathy of Prematurity (ROP) 17 111 Diseases That Interfere With Normal Feeding Ability 17 Infectious Diseases 17 Gonorrhea 18 Syphilis 18 Herpes 18 Chlamydia 18 Hepatitis B 19 Human Immunodeficiency Virus (HIV) 19 Tuberculosis (TB) 20 Fetal Alcohol Syndrome (FAS) 21 Sudden Infant Death Syndrome (SIDS) 21 Failure To Thrive (FTT) 21 Intrauterine Growth Retardation (IUGR) 22 Central Nervous System (CNS) Disorders 22 Medical Followup Recommendations 23 Developmental Concerns 25 Developmental Assessment 25 Developmental Patterns of Prenatally Drug-Exposed Children 26 Infancy (0 to 15 Months) 26 Toddlerhood (15 to 36 Months) 28 Preschool Years (3 to 5 Years) 29 School and Teenage Years 30 Summary 31 REPORTING CHILD MALTREATMENT IN CASES INVOLVING PARENTAL SUBSTANCE ABUSE 33 Reporting Obligations 33 Reporting Parental Substance Abuse 33 Reporting Substance Abuse During Pregnancy 33 Reporting Drug- and Alcohol-Affected Infants 34 Variations in Reporting 34 Confidentiality 34 COMPREHENSIVE FAMILY ASSESSMENT 39 Gathering Information 40 iv Interviews With Family Members 40 Home Visits 40 Collateral Contacts 40 Standardized Evaluations 40 Areas of Assessment 41 Assessment of the Infant and Child 41 Infant Assessment 41 Child Assessment 42 Assessment of the Adolescent 42 Assessment of the Parent 44 Substance Abuse History 44 Drug and Alcohol Treatment History 46 Health and Health Care 46 Mental Health and History of Psychiatric Treatment 46 Criminal History 47 Level of Cooperation 47 Awareness of the Impact of Drug and Alcohol Use on the Child 48 Parenting Skills and Responsiveness to Child 48 History of Abuse andlor Neglect 49 Work History and Education 49 Assessment of the Home Environment 49 Environmental Conditions of the Home 50 Partners or Parent Substitutes Within the Home 51 Family Support Systems 51 Assessment of Relative Caregivers 51 Parenting Skills and History of Abuse, Neglect, or Violence 52 Alcohol Use andlor Other Drug Use 52 Quality of the Relationship With the Parent and Ability to Protect and Nurture the Child 52 Cooperation, Receptivity, and Access to Services 53 Assessment of Foster Parents 53 Attitudes Toward Birth Parents 54 v Caregiving 54 Perception and Expectations of the Child 54 Receptivity to Services 55 Family Supports 55 Guides for Assessment 55 Summary 56 JUVENILE COURT INVOLVEMENT WITH CHEMICALLY INVOLVED FAMILIES 61 Considerations of the Juvenile Court in Cases of Parental Substance Abuse 62 Child's Health and Psychosocial Status 62 Child's Age 62 Parental History of Substance Abuse and Treatment 63 Parenting Profile 63 Home Environment 64 Family Supports 64 Treatment and Support Services 64 Special Issues Affecting Legal Interventions With Chemically Involved Families 65 Reasonable Efforts 65 Realistic Time Frames 66 Termination of Parental Rights 66 Permanent Placement 68 Adoption 68 Guardianship 68 Long-Term Foster Care 69 Summary 69 INNOVATIVE APPROACHES TO INTERVENTION: IMPROVING THE ODDS 71 Comprehensive Tr~atment Approaches 71 Programs for Pregnant and Parenting Women With Children 71 Residential Treatment 72 Specialized Child Protective Services (CPS) Units 73 Fawily Preservation Programs 73 Innovations in Out-Of-Home Care 74 Transitional Group Care for Foster Children 74 Specialized Foster Homes 74 vi Foster Parent Training 75 Grandparent Support Groups 76 Meeting Health and Educational Needs 76 Comprehensive Health Care Clinics for Substance-Affected Children 76 Early Childhood Programs 77 Support Programs for Parents 77 Twelve-Step Programs 77 Programs for Adolescents 78 Programs for Incarcerated Women 78 Day Treatment Programs for Pregnant Women and Their HusbandslPartners 79 Interagency Approaches 79 Interagency Coordinating Councils 79 Interagency, Interdisciplinary Training 80 Interagency Service Teams 80 Summary 81 CONCLUSION 83 APPENDICES Appendix I: The Nature of Substances of Abuse 85 Appendix II: Sample Medical Center Protocol 97 Appendix III: Sample Interagency Agreement 109 NOTES 113 GLOSSARY OF TERMS 117 SELECTED BIBLIOGRAPHY 121 OTHER RESOURCES 127 TABLES Table 1. Hospital Form for Discharge of Infants into Out-of-Home Care 24 Table 2. Sample Interagency Consent Form 37 Table 3. AssessmentlIntervention Guide: Biologic Family 57 Table 4. AssessmentlIntervention Guide: Relative Caregiver 59 Table 5. AssessmentlIntervention Guide: Foster Family 60 Table 6. Major Substances of Abuse 95 vii --------------------------~,., PREFACE The Child Abuse Prevention and Treatment Act was signed into law in 1974. Since that time, the Federal Government has served as a catalyst to mobilize society's social service, mental health, medical, education­ al, legal, and law enforcement resources to address the challenges in the prevention and treatment of child abuse and neglect. In 1977, in one of its early efforts to achieve this goal, the National Center on Child Abuse and Neglect (NCCAN) developed 21 manuals (the User Manual Series) to provide guidance to profession­ als involved in the child protection system and to enhance community collaboration and the quality of ser­ vices provided to children and families. The manuals described each professional's roles and responsibilities in the prevention, identification, and treatment of child maltreatment. Other manuals in the series addressed special topics, for example, adolescent abuse and neglect. Our understanding of the complex problems'of child abuse and neglect has increased dramatically since the user manuals were developed. This increased knowledge has improved our ability to intervene effectively in the lives of troubled families. Likewise, we have a better grasp of what we can do to prevent child abuse and neglect from occurring. Further, our knowledge of the unique roles key professionals can play in child pro­ tection has been more clearly defined, and a great deal has been learned about how to enhance coordination and collaboration of community agencies and professionals. Finally, we are facing today new and more seri­ ous problems in families who maltreat their children. For example, there is a significant percentage of fam­ ilies known to Child Protective Services (CPS) who are experiencing substance abuse problems. Because our knowledge base has increased significantly and the state of the art of practice has improved con­ siderably, NCCAN has updated the User Manual Series by revising many of the existing manuals and creat­ ing new manuals that address current innovations, concerns, and issues in the prevention and treatment of child maltreatment. This manual, Protecting Children in Substance-Abusing Families, is designed for professionals in the fields of child welfare, mental health, health care, education, law, the faith community, and substance abuse pre­ vention and treatment. The manual is intended to help professionals identify the various forms of parental substance abuse, assess the strengths and needs of families affected by alcohol and/or other drug abuse,
Load more

Recommended publications
  • Drug Threshold Enactments (2009-2015) 2015
    NCSL: Drug Threshold Enactments 2009-2015 Page | 1 Drug Threshold Enactments (2009-2015) 2015 Alabama SB 67 Lowers from a class C to class D felony first degree possession of marijuana if the person possesses marijuana for personal use after previously being convicted of certain marijuana possession offenses. Connecticut HB 7104 Reduces from a felony to a class A misdemeanor possession of any amount of illegal drug. Reduces from a felony to a class A misdemeanor possession of a half-ounce or more of marijuana. Kentucky SB 192 Creates a new class C felony of importing heroin and a new class B felony of aggravated trafficking in a controlled substance in the first degree if the substance trafficked was 100 grams or more of heroin. Increases the penalty from a class A misdemeanor to a class D felony for drug trafficking that involves more than 120 dosage units. Louisiana HB 149 Creates graduated penalties for first time possession of marijuana offenses by weight, reduces penalties for second and third convictions for possession of marijuana offenses, and creates a penalty for fourth conviction of possession of marijuana. • First offense possession of less than 14 grams of marijuana is punishable by not more than 15 days in jail and not more than $300. • First offense possession of more than 14 grams but less than two and a half pounds of marijuana is punishable by not more than six months jail and not more than $500. • Reduces second offense possession of marijuana from not more than 5 years and not less than $250 but not more than $2,000, to not more than 6 months in jail and nor more than $1,000.
    [Show full text]
  • Participant Handbook
    LOWNDES COUNTY DUI COURT PARTICIPANT HANDBOOK STATE COURT OF LOWNDES COUNTY 327 NORTH ASHLEY STREET VALDOSTA, GA 31601 PHONE: 229-671-2895 FAX: 229-671-3441 Lowndes County DUI Court Team: Ellen S. Golden Judge, State Court Cynthia Welch Assistant Solicitor-General Gee Edwards Defense Attorney Stacey Bass Court Coordinator Kayla Porter Probation Officer Laci Rankhorn Treatment Provider Jason Reeves Surveillance Officer Revised 3/1/19 1 | P a g e TABLE OF CONTENTS TABLE OF CONTENTS...........................................................................................................................2 INTRODUCTION TO THE LOWNDES COUNTY STATE COURT DUI COURT.......................... 4 TREATMENT OVERVIEW.................................................................................................................... 6 I. PHASES OF THE DUI COURT PROGRAM........................................................................................7 Phase 1 – (approximately 17 weeks)....................................................................................................7 Phase 2 – (approximately 17 weeks)................................................................................................... 8 Phase 3 – (approximately 17 weeks)................................................................................................... 9 Phase 4 Aftercare- (approximately 3 months)....................................................................................9 Phase Progression.........................................................................................................................
    [Show full text]
  • NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Amphetamine and Methamphetamine
    Published 2005 Wiley-Liss, Inc.w Birth Defects Research (Part B) 74:471–584 (2005) NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity Of Amphetamine and Methamphetamine Mari Golub,1 Lucio Costa,2 Kevin Crofton,3 Deborah Frank,4 Peter Fried,5 Beth Gladen6 Rogene Henderson,7 Erica Liebelt,8 Shari Lusskin,9 Sue Marty,10 Andrew Rowland11 John Scialli12 and Mary Vore13 1California Environment Protection Agency, Sacramento, California 2University of Washington, Seattle, Washington 3U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 4Boston Medical Center, Boston, Massachusetts 5Carleton University, Ottawa, Ontario 6National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 7Lovelace Respiratory Research Institute, Albuquerque, New Mexico 8University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 9New York University School of Medicine, New York, New York 10The Dow Chemical Company, Midland, Michigan 11University of New Mexico, Albuquerque, New Mexico 12Phoenix, Arizona 13University of Kentucky, Lexington, Kentucky PREFACE studies indexed before December 31, 2004. References were also identified from databases such as REPRO- The National Toxicology Program (NTP) and the TOXs, HSDB, IRIS, and DART and from report National Institute of Environmental Health Sciences bibliographies. (NIEHS) established the NTP Center for the Evaluation This evaluation resulted from the efforts of a 13- of Risks to Human Reproduction (CERHR) in June 1998. member panel of government and non-government The purpose of the Center is to provide timely, unbiased, scientists that culminated in a public expert panel scientifically sound evaluations of human and experi- meeting held January 10–12, 2005. This report is a mental evidence for adverse effects on reproduction and product of the Expert Panel and is intended to (1) development caused by agents to which humans may be interpret the strength of scientific evidence that exposed.
    [Show full text]
  • Overland Park, Kansas Municipal Code Table of Contents Title 1 - General Provisions 1.01 Code Adoption
    Overland Park, Kansas Municipal Code Table Of Contents Title 1 - General Provisions 1.01 Code Adoption. 1.01.010 Generally. 1.01.020 Publication-Effect. 1.01.030 Short Title-Citation-Reference. 1.01.040 Reference Applies to Amendments. 1.01.050 Title, Chapter and Section Headings. 1.01.060 Reference to Specific Ordinances. 1.01.070 Supplements Authorized. 1.01.080 Effect of Code on Past Actions and Obligations. 1.01.090 Effective Date of Code. 1.01.100 Ordinance Book Designated. 1.01.110 Constitutionality. 1.04 General Provisions 1.04.010 Definitions. 1.04.020 Grammatical Interpretation. 1.04.030 Prohibited Acts Include Causing, Permitting, and Related Acts. 1.04.040 Construction. 1.04.050 Repeal Not To Revive Any Ordinances. 1.08 Right of Entry for Inspection 1.08.010 Regulations Generally. 1.12 General Penalty 1.12.010 Designated. 1.16 Ward Boundaries (Repealed) 1.16.010 Division - Boundaries - Renumbering - Boundary Adjustment. 1.20 Official Newspaper (Repealed) 1.20.010 Exemption from K.S.A. 13-1420. 1.20.020 Governing Body to Designate Official Newspaper. 1.20.030 Official Designation. 1.20.040 Official Newspaper To Have Been Published for a Year. 1.20.050 More Than One Official Newspaper. 1.24 Citations for Violations 1.24.010 Definitions. 1.24.020 Notice To Appear. 1.24.030 Time Specified. 1.24.040 Municipal Court. 1.24.050 Distribution of Notice. 1.24.060 Complaint To Be Filed. 1.24.070 Chapter Inapplicable To Certain Violations. Legal Basis for Overland Park, Kansas Title 2 - Administration and Personnel Page 1 2.09 City Manager/Governing Body Article I.
    [Show full text]
  • Needle Sharing Among Intravenous Drug Abusers: National and International Perspectives
    Needle Sharing Among Intravenous Drug Abusers: National and International Perspectives U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Needle Sharing Among Intravenous Drug Abusers: National and International Perspectives Editors: Robert J. Battjes, D.S.W. Roy W. Pickens, Ph.D. Division of Clinical Research National Institute on Drug Abuse NIDA Research Monograph 80 1988 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science. The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. MARY L. JACOBSON Temple University School of Medrcrne National Federation of Parents for Philadelphia. Pennsylvania Drug-Free Youth Omaha, Nebraska SYDNEY ARCHER, Ph.D. Rensselaer Polytechnic Institute Troy, New York REESE T. JONES, M.D. Langley Porter Neuropsychiatric lnstitute RICHARD E. BELLEVILLE. Ph.D. San Francisco, California NB Associates, Health Sciences RockviIle, Maryland DENISE KANDEL, Ph.D. KARST J. BESTEMAN College of Physicians and Surgeons of Alcohol and Drug Problems Association Columbia University of North America New York, New York Washington, D.
    [Show full text]
  • Texas Controlled Substances Act
    HEALTH AND SAFETY CODE TITLE 6. FOOD, DRUGS, ALCOHOL, AND HAZARDOUS SUBSTANCES SUBTITLE C. SUBSTANCE ABUSE REGULATION AND CRIMES CHAPTER 481. TEXAS CONTROLLED SUBSTANCES ACT SUBCHAPTER A. GENERAL PROVISIONS Sec.A481.001.AASHORT TITLE. This chapter may be cited as the Texas Controlled Substances Act. Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. Sept. 1, 1989. Sec.A481.002.AADEFINITIONS. In this chapter: (1)AA"Administer" means to directly apply a controlled substance by injection, inhalation, ingestion, or other means to the body of a patient or research subject by: (A)AAa practitioner or an agent of the practitioner in the presence of the practitioner; or (B)AAthe patient or research subject at the direction and in the presence of a practitioner. (2)AA"Agent" means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser. The term does not include a common or contract carrier, public warehouseman, or employee of a carrier or warehouseman acting in the usual and lawful course of employment. (3)AA"Commissioner" means the commissioner of state health services or the commissioner 's designee. (4)AA"Controlled premises" means: (A)AAa place where original or other records or documents required under this chapter are kept or are required to be kept; or (B)AAa place, including a factory, warehouse, other establishment, or conveyance, where a person registered under this chapter may lawfully hold, manufacture, distribute, dispense, administer, possess, or otherwise dispose of a controlled substance or other item governed by the federal Controlled Substances Act (21 U.S.C.
    [Show full text]
  • DXM Fast Facts
    What is DXM? doses—usually at least half an 8-ounce ketamine. While under the influence of bottle—by drinking the liquid very the drug, which can last for as long as DXM (dextromethorphan) is a quickly. (Consumption of large quanti- 6 hours, DXM abusers risk injuring cough suppressant available in a ties of cough syrup induces vomiting. themselves and others because of the variety of over-the-counter cough and Thus, to achieve the desired effects, drug’s effects on visual perception and cold medications. DXM is abused abusers must drink the product quickly cognitive processes. because, when taken in doses that enough to allow the body to absorb the In addition, individuals who ingest dramatically exceed those recom- DXM before vomiting occurs.) mended by physicians and pharma- high doses of DXM risk hyperthermia cists, it produces hallucinations and The availability of powdered extrac- (exceptionally high fever), particularly if a sense of dissociation. tions of DXM has resulted in abusers they use the drug in a hot environment either inhaling the powder (snorting) or or while physically exerting themselves— What does DXM look like? repackaging it in capsules, which are such as at a rave or dance club. Other then swallowed. risks associated with DXM abuse As an over-the-counter medication, include nausea, abdominal pain, vomit- DXM is available in various forms Who abuses DXM? ing, irregular heartbeat, high blood including liquids, lozenges, tablets, pressure, headache, numbness of capsules, and gel caps. In addition, DXM It is difficult to gauge the extent of fingers and toes, loss of consciousness, powder—prepared by extracting the drug DXM abuse in the United States seizures, brain damage, and death.
    [Show full text]
  • Medical Marijuana
    Policy Newark Police Department 452 Newark PD Policy Manual Medical Marijuana 452.1 PURPOSE AND SCOPE The purpose of this policy is to provide members of this department with guidelines for investigating the acquisition, possession, transportation, delivery, production or use of marijuana under California’s medical marijuana laws. 452.1.1 DEFINITIONS Definitions related to this policy include: Cardholder - A person issued a current identification card. Compassionate Use Act (CUA) (Health and Safety Code § 11362.5) - California law intended to provide protection from prosecution to those who are seriously ill and whose health would benefit from the use of marijuana in the treatment of illness for which marijuana provides relief. The CUA does not grant immunity from arrest but rather provides an affirmative defense from prosecution for possession of medical marijuana. Identification card - A valid document issued by the California Department of Public Health to both persons authorized to engage in the medical use of marijuana and also to designated primary caregivers. Medical marijuana - Marijuana possessed by a patient or primary caregiver for legitimate medical purposes. Medical Marijuana Program (MMP) (Health and Safety Code § 11362.7 et seq.) - California laws passed following the CUA to facilitate the prompt identification of patients and their designated primary caregivers in order to avoid unnecessary arrests and provide needed guidance to law enforcement officers. MMP prohibits arrest for possession of medical marijuana in certain circumstances and provides a defense in others. Patient - A person who is entitled to the protections of the CUA because he/she has received a written or oral recommendation or approval from a physician to use marijuana for medical purposes or any person issued a valid identification card.
    [Show full text]
  • NSDUH MRB Instrumentation Protocol Changes
    Instrumentation Protocol Changes The 2015 National Survey on Drug Use and Health (NSDUH) instrumentation protocols underwent several modifications from the protocols employed for the 2014 NSDUH. A summary of the changes for the 2015 NSDUH can be divided into three topics: (1) the computer-assisted interviewing (CAI) tablet screening instrument, (2) the CAI questionnaire, and (3) the interviewer materials. 1. Screening Instrument Using the 2014 Screening Application as a base, questions, response options, and informed consent wording were modified for the 2015 Screening Application. Listed below are the Screening Application changes for 2015: • As necessary, dates were updated in the screening program. • As necessary, specification updates were made to reflect current tablet screening programming and format. • Response options in the Spanish-language screener have been translated into Spanish. • In the Study Introduction, "Research Triangle Institute" has been replaced with "RTI International," and "U.S. Public Health Service" has been replaced with "U.S. Department of Health and Human Services." • All ePTE data screens were removed. • Field Interviewer (FI) Debriefing Questions were moved from the CAI Questionnaire to the screening tablet, to be administered after leaving the household. They are now documented as "Section 9, FI Debriefing Questions," within the NSDUH Screening Specifications document. 2. CAI Questionnaire Using the 2014 CAI Questionnaire as a base, questions and routing were modified for the 2015 CAI Questionnaire. Listed below are the CAI Questionnaire changes for 2015: Introduction • The CAI instrument version, Office of Management and Budget (OMB) control number, and OMB expiration date were updated in the Introduction section. • The OMB control number was also updated in the Public Reporting Burden statement.
    [Show full text]
  • Cocaine Use a Problem? A
    ? Q&A Q. IS COCAINE USE A PROBLEM? A. YES. There were 1.9 million current (past-month) cocaine users ages 12 or older in 2015.11 About 900,000 users ages 12 or older met the criteria for a diagnosable disorder with significant negative effects because of COCAINE 12 their cocaine use in the past year. In 2014, overdoses and deaths caused by cocaine use increased by 42 THE TRUTH ABOUT COCAINE percent.13 Q. WHAT IS THE DIFFERENCE BETWEEN COCAINE SLANG: COKE/FLAKE/C/COCA/BUMP/ AND CRACK? COCAINE IS A WHITE POWDER that can be snorted or TOOT/SNOW/BLOW/ROCK (CRACK) A. dissolved in water and injected. Crack, an altered form of cocaine, is a rock crystal that is usually smoked.14 GET THE FACTS Q. WHAT IS THE MOST DANGEROUS WAY TO USE COCAINE AFFECTS YOUR BRAIN. Cocaine causes a brief high COCAINE? that makes the user feel more energetic, talkative, and alert; this ANY METHOD OF COCAINE USE CARRIES A RISK can be followed by feelings of restlessness, irritability, and panic.1 A. of addiction and/or overdose.15 Snorting cocaine can Cocaine is highly addictive and can increase the risk of negative result in frequent nosebleeds or loss of sense of smell. psychological states, including paranoia, anxiety, and psychosis.2,3 Injecting cocaine can cause infected sores at the COCAINE AFFECTS YOUR BODY. People who use cocaine often injection sites or exposure to serious diseases such as don’t eat or sleep regularly. They can experience increased heart HIV and hepatitis C by sharing needles.
    [Show full text]
  • An Ordinaj4ce to Regulate the Dispensing of Medical Ma1ujijana
    ORDINANCE NO: 2013-1 AN ORDINAJ4CE TO REGULATE THE DISPENSING OF MEDICAL MA1UJIJANA THE CITY OF EVART ORDAINS: MEDICAL MARIJUANA DISPENSARy Section 1: Definitions A. City means: City ofEvart B. ‘Primary Caregiver”: A person who is operating a “Medical Marijuana Dispensary” by supplying “Medical Marijuan&’ for up to (5) “qualifying patients,” and who is registered with the Michigan Department of Community Health or successor agency hereinafter referred to as “Department” for such purpose. C. “Medical Marijuana Dispensary”: A thcility where a ‘Primary Caregiver” who is legally registered by the Department may lawfiully assist upto (5) “qualifying patients” who are also legally registered by the Department with the acquisition of medical marijuana in accordance with the Michigan Medical Marijuana Act of 2008. D. “Marijuana?’: means that term as defined in Section 7106 of the Public Health Cod; 1978 PA 368, MCL 333.7106. B. “Medical Use”: means the acquisition, possession, cultivation, manufacture, use, internal possession, delivery, transfer or transportation of marijuana or paraphernalia relating to the administration of marijuana to treat or alleviate a registered “qualifying patient’s” debilitating medical condition. F. “Qualifying Patient”: A person who has obtained a valid registration card from the Department allowing them to possess and purchase medical marijuana. Section 2: Purpose and Intent: It is determined necessary for the health, safety and welfare of the City to adopt this Ordinance regulating the location and operation of “Medical Marijuana Dispensaries” due to the following factors: A. Outside the purview of the Michigan Medical Marijuana Act the possession and use of marijuana (a Schedule I Drug) in the State of Michigan remains a misdemeanor offense.
    [Show full text]
  • Ordinance No. 180 an Ordinance to Prohibit the Use, Possession, Delivery, Sale, Or Advertisement of Drug Paraphernalia and the E
    ORDINANCE NO. 180 AN ORDINANCE TO PROHIBIT THE USE, POSSESSION, DELIVERY, SALE, OR ADVERTISEMENT OF DRUG PARAPHERNALIA AND THE ESTABLISHMENT OR OPERATION OF A MEDICAL MARIJUANA AKA MARIHUANA DISPENSARY IN THE VILLAGE OF DECATUR, MICHIGAN. THE VILLAGE OF DECATUR, VAN BUREN COUNTY, MICHIGAN ORDAINS: Section 1: DEFINITIONS RELATING TO DRUG PARAPHERNALIA. A. The term “drug paraphernalia” means all equipment, products and materials of any kind which is used, intended for use, or designed for use, in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance as defined in Section 7104 of the Michigan Public Health Code (Act No. 368 of the MI Public Acts of 1978, as Amended), in violation of the laws of the State of Michigan. It includes, but is not limited to: 1. Kits used, intended for use, or designed for use in planting, propagating, cultivating, growing or harvesting of any species of plant which is a controlled substance or from which a controlled substance can be derived; 2. Kits used, intended for use, or designed for use in manufacturing, compounding, converting, producing, processing, or preparing controlled substances; 3. Isomerization devices used, intended for use, or designed for use in increasing the potency of any species of plant which is a controlled substance; 4. Testing equipment used, intended for use, or designed for use in identifying or in analyzing the strength, effectiveness or purity of controlled substances; 5. Scales and balances used, intended for use, or designed for use in weighing or measuring controlled substances; 6.
    [Show full text]